Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow the sutures
2017-002516-13Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in chronic migraine, sponsored by St. Olavs University Hospital. Primary endpoint: Tolerability and safety of injection procedure. Started Mar 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on 2017-002516-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002516-13.